Table 4.
Odds of IAHBc against immunized serology.
| Categories | Odds Ratio (95% CI) |
|---|---|
| Family History of HBV | |
| Yes | 0.74 (0.07, 4.37) |
| No | Ref. |
| Don't Know | 1.23 (0.20, 6.10) |
| Family History of HCC | |
| Yes | 1.80 (0.15, 15.18) |
| No | Ref. |
| Don't Know | 5.00 (0.60, 59.44) |
| Primary Care Provider | |
| Yes | 1.02 (0.29, 3.73) |
| No | Ref. |
| Insurance | |
| Yes | 1.55 (0.44, 6.09) |
| No | Ref. |
| Seen by Provider in the Past Year | |
| Yes | 0.78 (0.21, 3.14) |
| No | Ref. |
| Vaccination | |
| Yes | 1.37 (0.30, 8.31) |
| No | Ref. |
| Tested for HBV in the Past | |
| Yes | 0.52 (0.09, 2.36) |
| No | Ref. |
| Year Arrived in the US | |
| Before 1990 | Ref. |
| 1990–1999 | 0.20 (0.01, 5.45) |
| 2000–2009 | 1.52 (0.22, 10.38) |
| 2010–2019 | 0.70 (0.11, 4.67) |
| 2020+ | 0.36 (0.03, 3.72) |
| Region of Birth | |
| Western Pacific | 1.22 (0.05, 29.96) |
| Africa | 6.27 (0.31, 128.00) |
| Americas | Ref. |
HBV, hepatitis B virus; HCC, hepatocellular carcinoma; IAHBc, Isolated anti-hepatitis B core.
Note: Maximum iterations = 250; maximum beta step size = 5; maximum step halving = 5; Log-Likelihood Convergence Criterion = 0.00001; Beta Change Convergence Criterion = 0.000.